PharmaCorp RxTSXV:PCRX 35 Market Cap is C$87.04 Mil as of Jun. 30, 2026. GuruFocus rates TSXV:PCRX with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 694 Healthcare Providers & Services companies, PharmaCorp Rx ranks worse than 56.77% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PharmaCorp Rx's share price for the quarter that ended in Mar. 2026 was C$0.435. PharmaCorp Rx's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 174.08 Mil. Therefore, PharmaCorp Rx's market cap for the quarter that ended in Mar. 2026 was C$75.73 Mil.
PharmaCorp Rx's quarterly market cap
increased
from Sep. 2025 (C$55.72 Mil) to Dec. 2025 (C$79.21 Mil) but then
declined
from Dec. 2025 (C$79.21 Mil) to Mar. 2026 (C$75.73 Mil).
PharmaCorp Rx's annual market cap
increased
from Dec. 2023 (C$8.46 Mil) to Dec. 2024 (C$63.34 Mil) and
increased
from Dec. 2024 (C$63.34 Mil) to Dec. 2025 (C$79.21 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PharmaCorp Rx's Enterprise Value for Today is C$68.57 Mil.
PharmaCorp Rx (TSXV:PCRX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PharmaCorp Rx Market Cap Related Terms
PharmaCorp Rx Market Cap Historical Data
* Premium members only.
The historical data trend for PharmaCorp Rx's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, PharmaCorp Rx's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaCorp Rx Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmaCorp Rx's Market Cap distribution charts can be found below:
* The bar in red indicates where PharmaCorp Rx's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PharmaCorp Rx's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmaCorp Rx (TSXV:PCRX) has a Market Cap of C$87.04 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PharmaCorp Rx and its competitors. According to the industry distribution chart, PharmaCorp Rx ranks #394 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 56.8%.
Is PharmaCorp Rx's Market Cap too high?
PharmaCorp Rx's current Market Cap is C$87.04 Mil. Based on the distribution chart, PharmaCorp Rx ranks #394 out of 694 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PharmaCorp Rx has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, PharmaCorp Rx ranks #394 out of 694 companies for Market Cap. This places PharmaCorp Rx in the lower half of its industry. The industry median Market Cap is 95.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 95.86, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PharmaCorp Rx and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 95.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaCorp Rx's current Market Cap is C$87.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Market Cap of C$87.04 Mil. The current Market Cap is C$87.04 Mil. PharmaCorp Rx's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Market Cap is C$87.04 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
35GF Score
Get the complete analysis for TSXV:PCRX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PCRX has been successfully added to your 
